VG LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | 0.00% |
|
0.00% | +9,900.00% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2013 | - | Sales 2014 | - | Capitalization | 2.23M 3.03M |
|---|---|---|---|---|---|
| Net income 2013 | -7M -9.53M | Net income 2014 | -6M -8.17M | EV / Sales 2013 | - |
| Net Debt 2013 | 2.49M 3.4M | Net Debt 2014 | 3.83M 5.21M | EV / Sales 2014 | - |
| P/E ratio 2013 |
-0.25
x | P/E ratio 2014 |
-0.31
x | Employees | 1 |
| Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.01
5 years
0.000.03
10 years
0.000.19
| Managers | Title | Age | Since |
|---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 16-12-31 |
Ana Gois
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 16-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 0.0001 | 0.00% | 6,869,582 |
| 24-05-16 | 0.0001 | +100.00% | 800,000 |
| 24-05-15 | 0.00005 | 0.00% | 3,470,400 |
| 24-05-14 | 0.00005 | -50.00% | 3,350,471 |
| 24-05-13 | 0.0001 | +100.00% | 8,964,487 |
Delayed Quote OTC Markets, May 17, 2024 at 03:53 pm
More quotes
VG Life Sciences Inc. is engaged in research and development of therapeutic and diagnostic pharmaceutical and medical products. The Company has not generated any revenue.
| 1st Jan change | Capi. | |
|---|---|---|
| +9,900.00% | 2.11M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
- Stock Market
- Equities
- VGLS Stock
